The global stem cells market size is expected to be worth around USD 17.79 billion by 2027 and poised to grow at a CAGR of 8.61% during the forecast period 2022 to 2027.
The global stem cells market size is expected to be worth around USD 17.79 billion by 2027 and poised to grow at a CAGR of 8.61% during the forecast period 2022 to 2027.
The global stem cells market size was valued at USD 9.3 billion in 2020, according to new study by Precedence Research
Growth Factors
In the body, stem cells are employed to cure a variety of diseases. The major market players in the stem cells market may benefit from technological improvements in the pharmaceutical and healthcare industries. The global stem cells market is being driven by increased spending in research and development activities to discover new ways to utilize stem cells in various healthcare applications. The demand for stem cells is increasing as disorders including diabetes, cancer, and heart diseases become more prevalent. The major market players in the stem cells market are experimenting with novel ways to culture and use stem cells in a variety of applications. The stem cells market is growing due to the rapid expansion of pharmaceutical corporations and clinical research institutes in developed areas.
Get the Sample Copy of Report@ https://www.precedenceresearch.com/sample/1118
Stem cellsare frequently used in regenerative medicine, particularly in dermatology. However, due to large number of pipeline medicines for the treatment of tumors or cancers, oncology is predicted to increase at the fastest rate. The stem cells industry is likely to grow in the future as the number of regenerative medicine facilities increases. Thus, increasing demand for biologics, technological advancements in stem cells treatments and growing focus on the development of tailored medications are all contributing to the stem cells market growth.
| Report Coverage | Details |
| Market Size in 2020 | USD 9.3 Billion |
| Growth Rate from 2021 to 2027 | 8CAGR of .61% |
| Base Year | 2021 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Companies Covered | STEMCELL Technologies, Inc., Cynata Therapeutics, Osiris therapeutics, Inc., Human Longevity, Inc., Merck Group, Advanced Cell Technology, Inc., BIOTIME, Inc.Mesoblast Limited, Promethera Biosciences S.A. N.V., Takara Bio Group. |
Report Highlights:
- Based on the application, the oncology segment dominated the global stem cells market in 2020 with highest market share. This is due to the presence of a number of pipeline products for the treatment of tumors and cancer.
- Based on the product, the adult stem cells segment dominated the global stem cells market in 2020 with highest market share. The inclusion of minimally problematic concerns addressing ethics, immune rejection, and cancer were the key causes that contributed to the segment’s domination.
- Based on the technology, the cell acquisition segment dominated the global stem cells market in 2020 with highest market share. As people become more aware of the exponential importance of stem cells, cell harvesting has increased significantly, resulting in rise in the global stem cells market.
- Based on the therapy, the allogeneic stem cell therapy segment dominated the global stem cells market in 2020 with highest market share. Due to their graft versus cancer impact, allogeneic cells are frequently employed in cancer treatment. The donor’s stem cells can employ their immune system cells to attack cancer cells due to their effect.
- North America is the largest segment for stem cells market in terms of region. This is attributed to the number of factors including the existence of important businesses involved in stem cell therapy development, significant research and development, sophisticated healthcare infrastructure, supporting reforms from healthcare organizations, and robust reimbursement policies.
- Asia-Pacific region is the fastest growing region in the stem cells market. This is due to the rising development of stem cell-based therapies, the establishment of several stem cell banks, government initiatives for developing regenerative medicines, and rising clinical trials for regenerative medicines.
Ask here for customization study@ https://www.precedenceresearch.com/customization/1118
Future of Stem cells Market
Adult stem cells that have been genetically reprogrammed to resemble embryonic stem cells are known as induced pluripotent stem cells. These stem cells are comparable to embryonic stem cells in that they have the ability to differentiate into specialized tissue cells based on gene expression, making them viable alternative to embryonic stem cells. These stem cells are involved with social and ethical issues and legislation pertaining to abortion, contraception, and in vitro fertilization because they are derived from early-stageembryos. The use of induced pluripotent stem cells avoids the use of human embryos, avoiding social and ethical concerns. All these advantages will create lucrative opportunities for the growth of the stem cells market in near future.
COVID-19 Impact Analysis:
- The pandemic of COVID-19 had a beneficial effect on the stem cells market.
- The product’s use in the treatment of a novel coronavirus has sparked interest in the medical community, resulting in an increase in clinical trials.
Key Developments in the Marketplace:
- Cipla and Stempeutics partnered in August 2020 to launch Stempucel cell therapy to treat critical limb ischemia.
- OrganaBio released the HematoPAC HSC-CB CD34 hematopoietic stem cells product in March 2021, which aids in the development of HSC-based allogeneic cell therapies.
- Stemedica Cell Technologies gained IND approval form the US FDA in September 2020 for intravenous allogeneic mesenchymal stem cells to treat moderate to severe COVID-19.
- Pluristem Israel and Abu Dhabi Stem Cells Center partnered in August 2020 to research stem cells therapies for COVID-19 therapy.
- Mesoblast Ltd partnered with Swiss pharmaceutical company Novartis in November 2020 to manufacture, develop, and market Mesoblast’s mesenchymal stromal cell product.
Market Segmentation
By Product
- Adult Stem Cells
- Neuronal Stem Cells
- Mesenchymal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Adipose-derived Stem Cells
- HematopoieticStem Cells
- Dedifferentiated fat (DFAT) Cells
- Other ASC’s
- Very Small Embryonic Like Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
By Application
- Regenerative Medicine
- Neurology
- Oncology
- Hematology
- Injuries
- Orthopedics
- Incontinence
- Diabetes
- Liver Disorder
- Others
- Drug Discovery and development
By Technology
- Cell Acquisition
- Apheresis
- Bone Marrow Harvest
- Umbilical Blood Cord
- Cryopreservation
- Cell production
- Therapeutic Cloning
- Cell Culture
- In-Vitro fertilization
- Isolation
- Expansion and Sub-Culture
By Therapy
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
By Regional Outlook
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1118
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333